• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission.

作者信息

Fiore J R, Jansson M, Scarlatti G, Angarano G, Caputo S L, Buccoliero G, Rossi P, Fenyö E M, Pastore G

机构信息

Clinic of Infectious Diseases, University of Bari, Italy.

出版信息

AIDS. 1993 Jan;7(1):29-31. doi: 10.1097/00002030-199301000-00004.

DOI:10.1097/00002030-199301000-00004
PMID:7680206
Abstract

OBJECTIVE

To evaluate the correlation between seroreactivity to peptides corresponding to the V3 loop of the major envelope glycoprotein from different HIV-1 strains and the risk of heterosexual HIV-1 transmission.

METHODS

Sera from 39 infected individuals (16 transmitters and 23 non-transmitters) were tested for reactivity against synthetic peptides representing sequences of the V3 loop apex from HIV-1 strains MN, SC, WMJ2, RF and IIIB.

RESULTS

A skewed distribution in seroreactivity to RF and IIIB peptides was observed between the two groups: reactivity was more prevalent in sera from non-transmitting than from transmitting individuals. Reactivity to the MN, SC and WMJ2 peptides was very frequent and there were no differences between the two groups.

CONCLUSION

These data suggest that antibodies reactive with a larger set of V3 apex peptides (i.e., cross-reactive antibodies) could play a role in the prevention of heterosexual transmission.

摘要

相似文献

1
Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission.
AIDS. 1993 Jan;7(1):29-31. doi: 10.1097/00002030-199301000-00004.
2
Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.1988年至1993年间,在感染了1型艾滋病毒的埃塞俄比亚人中,V3环抗体识别模式没有变化的证据。
AIDS Res Hum Retroviruses. 1994 Nov;10(11):1551-6. doi: 10.1089/aid.1994.10.1551.
3
Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.乌干达抗血清与人免疫缺陷病毒1型V3环表位编码肽的反应
AIDS Res Hum Retroviruses. 1994 May;10(5):577-83. doi: 10.1089/aid.1994.10.577.
4
A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.一项关于具有天然和嵌合序列的合成HIV-1肽与津巴布韦、坦桑尼亚和瑞典HIV-1阳性血清反应性差异的调查。
AIDS. 1993 Jun;7(6):759-67. doi: 10.1097/00002030-199306000-00002.
5
High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.非洲和美洲血清中针对HIV-1MN主要中和决定簇gp120 V3区域的抗体高流行率。
AIDS Res Hum Retroviruses. 1991 Oct;7(10):831-8. doi: 10.1089/aid.1991.7.831.
6
Seroreactivity of analogous antigenic epitopes in glycoprotein 120 expressed in HIV-1 subtypes A, B, C, and D.在HIV-1 A、B、C和D亚型中表达的糖蛋白120中类似抗原表位的血清反应性。
AIDS Res Hum Retroviruses. 1995 May;11(5):589-96. doi: 10.1089/aid.1995.11.589.
7
Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV-1ANT-70 isolate in human sera from different geographic regions.来自不同地理区域人类血清中针对源自黑猩猩慢病毒和不同的HIV-1 ANT-70分离株的V3环肽的抗体。
AIDS. 1994 Dec;8(12):1657-61. doi: 10.1097/00002030-199412000-00003.
8
Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study.孕妇针对gp120 V3环肽的抗体与围产期HIV-1传播之间缺乏相关性。纽约市围产期HIV传播协作研究。
AIDS. 1991 Oct;5(10):1179-84. doi: 10.1097/00002030-199110000-00004.
9
V3 loop core region serotyping of HIV-1 infected patients using the FHV epitope presenting system.使用FHV表位呈递系统对HIV-1感染患者进行V3环核心区域血清分型
J Virol Methods. 1997 Jan;63(1-2):121-7. doi: 10.1016/s0166-0934(96)02120-9.
10
Anti-HIV-1 seroreactivity and HIV transmission route[R1]. The HEC/FIOCRUZ AIDS Clinical Research Group.抗HIV-1血清反应性与HIV传播途径[R1]。巴西国家公共卫生学院/巴西奥斯瓦尔多·克鲁兹基金会艾滋病临床研究小组。
J Clin Virol. 1999 Jan;12(1):27-36. doi: 10.1016/s0928-0197(98)00068-3.